Research Study for Patients With Metastatic Renal Cell Carcinoma

NCT00110344 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Renal Cell

Interventions

DRUG: Nexavar (Sorafenib, BAY43-9006)
DRUG: Placebo

Sponsor

Bayer